Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Milestone Scientific ( (MLSS) ) has shared an announcement.
On April 30, 2026, Milestone Scientific’s compensation committee approved a one-time stock option exchange for underwater options held by CEO Eric Hines and senior sales executive Jason Papes, resetting the exercise price to $0.31 per share, matching the market price, while keeping the same total shares and extending front‑loaded vesting to strengthen retention. The committee also approved a new performance-based RSU sub-plan, covering up to 17.23 million shares over a 2026–2029 performance period and initially granting 11.2 million PRSUs to top executives, tying payouts to ambitious revenue, market capitalization, and acquisition milestones to align management incentives with shareholder value without significant additional cash outlays.
The option repricing consolidates more shares into earlier vesting dates, increasing near-term incentives for key leaders while avoiding incremental dilution or cash bonuses, reflecting concern over the diminished motivational value of options issued in August 2025 at higher strike prices. The PRSU framework, including caps on individual allocations and strict forfeiture and clawback terms, is structured to retain senior talent, drive organic growth and strategic M&A, and position Milestone Scientific for long-term expansion and potential re-rating in the capital markets.
The most recent analyst rating on (MLSS) stock is a Buy with a $1.00 price target. To see the full list of analyst forecasts on Milestone Scientific stock, see the MLSS Stock Forecast page.
Spark’s Take on MLSS Stock
According to Spark, TipRanks’ AI Analyst, MLSS is a Neutral.
The score is held down primarily by weak financial performance (persistent losses, ongoing cash burn, and a reduced equity cushion). Offsetting factors include improved operating loss trends and optimistic 2026 guidance from the earnings call, plus supportive recent financing, while technicals are broadly neutral and valuation remains constrained by unprofitability.
To see Spark’s full report on MLSS stock, click here.
More about Milestone Scientific
Milestone Scientific Inc. is a medical technology company that develops and commercializes computer-controlled injection systems and related dental and medical devices. The company focuses on improving the safety, efficacy, and patient comfort of drug delivery, targeting dental practices and broader healthcare markets seeking more precise, less painful injections.
Average Trading Volume: 2,095,121
Technical Sentiment Signal: Sell
Current Market Cap: $28.55M
For detailed information about MLSS stock, go to TipRanks’ Stock Analysis page.